{{flagHref}}
Products
  • Products
  • Categories
  • Blog
  • Podcast
  • Application
  • Document
|
/ {{languageFlag}}
Select language
Stanford Advanced Materials {{item.label}}
Stanford Advanced Materials
Select language
Stanford Advanced Materials {{item.label}}
a

Metal complexes in cancer therapy – an update from drug design perspective

Title Metal complexes in cancer therapy – an update from drug design perspective
Authors Umar Ndagi, Ndumiso Mhlongo, Mahmoud E Soliman
Magazine Drug Design, Development and Therapy
Date 03/03/2017
DOI 10.2147/DDDT.S119488
Introduction Historically, metal-based compounds were extensively applied in treating various diseases, but differentiating therapeutic and toxic doses posed significant challenges. The introduction of cisplatin by Barnett Rosenberg in 1960 marked a pivotal moment for metal-based cancer treatments, establishing the groundwork for contemporary metal-based anticancer drugs. Platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin dominate cancer treatment; however, the slower development of other metal-based compounds has hindered research progress. Recently, efforts have intensified to enhance and create novel metal-based compounds and nonclassical platinum complexes with unique mechanisms of action distinct from traditional drugs such as cisplatin. Numerous compounds have been synthesised by altering existing chemical structures or constructing entirely new compounds with improved safety and cytotoxic profiles. Due to the increased focus on the clinical significance of metal-based complexes, a few are undergoing clinical trials, with more awaiting ethical approval. This review aims to provide an overview of past studies on the cytotoxic effects of metal-based complexes, highlighting newly designed complexes and their impact on cancer cell lines, as well as innovative approaches to metal-based drug design and molecular targets in cancer therapy. We remain hopeful that selective targeting represents the future in developing therapies that specifically target cancer cells while sparing healthy cells.
Quote Umar Ndagi, Ndumiso Mhlongo and Mahmoud E Soliman. Metal complexes in cancer therapy – an update from drug design perspective. Drug Des Devel Ther. 2017. Vol. 11:599-616. DOI: 10.2147/DDDT.S119488
Element Platinum (Pt)
Topics Biomedical Materials
Related papers
Loading... Please wait...
Publish your research and articles on the SAM website
Disclaimer
This site only provides metadata for academic works to enable users to easily find relevant information. For full access to the works, please use the DOI to visit the original publisher's website. The data comes from publicly accessible scientific databases and complies with the terms of use of these platforms. If you have any concerns regarding copyright, please contact us. We will address them immediately.

Success! You are now subscribed.

You have successfully subscribed! Check your inbox soon to receive great emails from this sender.
Leave A Message
Leave A Message
* Your Name:
* Your Email:
* Product Name:
* Your Phone:
* Comments: